临床表现 临床表现
Kelly Rombauts1,2,3, Johan Skoog1,2,3, Tobias Skillbäck1,2,3
1Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
较低的粉样蛋白-β42/40 (Aβ) 水平与老年人更快的认知处理速度下降有关. 女性表现出比男性慢的认知衰退率,独立于Aβ水平.
科学领域:
- 神经学 神经学
- 老年学是一门学科.
- 生物化学 生物化学
背景情况:
- 在临床前阿尔茨海默氏症中早期发现认知能力下降对于干预至关重要.
- 大脑脊髓液 (CSF) 中的粉样蛋白-β42/40 (Aβ) 的比例是一个潜在的生物标志物.
- 需要对基于人口的群体进行纵向研究,以了解Aβ在认知衰老中的作用.
研究的目的:
- 在70岁的70岁人群中,研究脑脊液Aβ42/40水平与5-7年内认知衰退之间的关联.
- 检查特定认知领域的变化和复合认知评分.
- 为了探索潜在的认知衰退率的性别差异.
主要方法:
- 在H70哥德堡出生队列研究中,对250名参与者 (起始年龄为70岁) 的CSF Aβ42,Aβ40,t-tau和p-tau进行分析.
- 认知功能通过11个神经心理测试在6个领域进行评估,结合成一个复合得分.
- 多重线性回归模型根据年龄,性别和教育情况进行调整,以评估Aβ42/40与认知变化的关联.
主要成果:
- 较低的CSF Aβ42/40水平与处理速度 (β=0.123) 的较大下降相关.
- 在Aβ42/40与其他认知领域的变化或复合得分之间没有发现显著的关联.
- 与男性相比,女性的综合认知评分下降速度较慢 (β=0.248),独立于Aβ42/40.
结论:
- 减少的CSF Aβ42/40可能会先于更广泛的认知衰退,特别影响处理速度.
- 在70至76岁之间,女性的认知能力下降的进展比男性慢.
- 脑脊髓Aβ42/40比率是早期认知变化的相关生物标志物,特别是处理速度下降.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
516
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
516
Coronary Artery Disease III: Clinical Manifestations
295
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
295
Endocarditis II: Clinical Features of Infective Endocarditis
358
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
358
Heart Failure III: Clinical Manifestations
430
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
430
Gastroesophageal Reflux Disease II: Clinical Features and Management
647
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
647
Hypertension III: Clinical Manifestations and Diagnostic Studies
433
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433


